167 related articles for article (PubMed ID: 11559568)
1. Cortactin potentiates bone metastasis of breast cancer cells.
Li Y; Tondravi M; Liu J; Smith E; Haudenschild CC; Kaczmarek M; Zhan X
Cancer Res; 2001 Sep; 61(18):6906-11. PubMed ID: 11559568
[TBL] [Abstract][Full Text] [Related]
2. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
Peyruchaud O; Winding B; Pécheur I; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2001 Nov; 16(11):2027-34. PubMed ID: 11697798
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
Patel AS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
5. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
Bouvet M; Tsuji K; Yang M; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2006 Dec; 66(23):11293-7. PubMed ID: 17145875
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
7. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
9. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
12. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
14. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors.
Yang M; Reynoso J; Jiang P; Li L; Moossa AR; Hoffman RM
Cancer Res; 2004 Dec; 64(23):8651-6. PubMed ID: 15574773
[TBL] [Abstract][Full Text] [Related]
15. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts direct bystander killing of cancer cells in vitro.
Ramnaraine M; Pan W; Clohisy DR
Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
[TBL] [Abstract][Full Text] [Related]
19. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
20. In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis.
Hasegawa S; Yang M; Chishima T; Miyagi Y; Shimada H; Moossa AR; Hoffman RM
Cancer Gene Ther; 2000 Oct; 7(10):1336-40. PubMed ID: 11059691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
